• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性非髓样甲状腺癌

Familial nonmedullary thyroid carcinoma.

作者信息

Malchoff Carl D, Malchoff Diana M

机构信息

Division of Endocrinology, University of Connecticut Health Center, Farmington, CT 06030, USA.

出版信息

Cancer Control. 2006 Apr;13(2):106-10. doi: 10.1177/107327480601300204.

DOI:10.1177/107327480601300204
PMID:16735984
Abstract

BACKGROUND

Nonmedullary thyroid carcinomas (NMTCs) originate from the thyroid epithelial cells and, until recently, were thought to arise sporadically without an inherited genetic predisposition. However, evidence of a familial predisposition to NMTC is accumulating.

METHODS

This review addresses the strengths, weaknesses, and clinical implications of the observations indicating an inherited genetic predisposition to NMTC. These observations include epidemiologic studies, descriptions of large kindreds, and genetic analyses.

RESULTS

Familial NMTC (FNMTC) may be caused by an inherited genetic predisposition and can be divided into two groups. The first group has an increased prevalence of NMTC within a familial cancer syndrome with a preponderance of nonthyroidal tumors. In the second group the predominant neoplasm is NMTC, although other neoplasms may occur with increased frequency. These disorders are the focus of this review.

CONCLUSIONS

A family history in NMTC patients should be directed at detecting those familial tumor syndromes with a preponderance of NMTC as well as those familial tumor syndromes enriched in NMTC but with a preponderance of nonthyroidal tumors. Since the recurrence rates may be greater in FNMTC than in sporadic NMTC, careful monitoring is indicated for affected individuals. The advantages and disadvantages of screening asymptomatic members of FNMTC kindreds with thyroid ultrasound are discussed, and the final decision is deferred to the treating physicians and their patients. It is hoped that positional cloning research will identify the FNMTC susceptibility genes.

摘要

背景

非髓样甲状腺癌(NMTC)起源于甲状腺上皮细胞,直到最近,人们还认为其是散发性发生的,不存在遗传易感性。然而,越来越多的证据表明NMTC存在家族易感性。

方法

本综述探讨了表明NMTC存在遗传易感性的观察结果的优势、劣势及临床意义。这些观察结果包括流行病学研究、大家族描述及基因分析。

结果

家族性NMTC(FNMTC)可能由遗传易感性引起,可分为两组。第一组在家族性癌症综合征中NMTC患病率增加,且以非甲状腺肿瘤为主。第二组以NMTC为主要肿瘤,尽管其他肿瘤的发生频率可能增加。这些疾病是本综述的重点。

结论

NMTC患者的家族史应旨在检测以NMTC为主的家族性肿瘤综合征以及富含NMTC但以非甲状腺肿瘤为主的家族性肿瘤综合征。由于FNMTC的复发率可能高于散发性NMTC,因此建议对受影响个体进行密切监测。讨论了用甲状腺超声筛查FNMTC家族无症状成员的利弊,最终决定留给治疗医生及其患者。希望定位克隆研究能够鉴定出FNMTC易感基因。

相似文献

1
Familial nonmedullary thyroid carcinoma.家族性非髓样甲状腺癌
Cancer Control. 2006 Apr;13(2):106-10. doi: 10.1177/107327480601300204.
2
Familial nonmedullary thyroid carcinoma.家族性非髓样甲状腺癌
Semin Surg Oncol. 1999 Jan-Feb;16(1):16-8. doi: 10.1002/(sici)1098-2388(199901/02)16:1<16::aid-ssu4>3.0.co;2-7.
3
Familial nonmedullary thyroid carcinoma.家族性非髓样甲状腺癌
Thyroid. 2013 Sep;23(9):1049-56. doi: 10.1089/thy.2013.0079. Epub 2013 Aug 3.
4
The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases.第二代家族性非髓样甲状腺癌的长期预后比散发性病例更具侵袭性。
Thyroid. 2012 Apr;22(4):356-62. doi: 10.1089/thy.2011.0163. Epub 2012 Jan 26.
5
In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease.在滤泡细胞来源的甲状腺癌患者中,一级亲属中有非髓样甲状腺癌家族史与更具侵袭性的疾病相关。
Thyroid. 2012 Jan;22(1):3-8. doi: 10.1089/thy.2011.0192. Epub 2011 Dec 2.
6
The familial counterparts of follicular cell--derived thyroid tumors.
Int J Surg Pathol. 2010 Aug;18(4):233-42. doi: 10.1177/1066896910366442. Epub 2010 May 5.
7
Genetic aspects of familial thyroid cancer.家族性甲状腺癌的遗传学方面
Oncologist. 2009 Jun;14(6):571-7. doi: 10.1634/theoncologist.2009-0046. Epub 2009 May 22.
8
Familial nonmedullary thyroid cancer: a review of the genetics.家族性非髓样甲状腺癌:遗传学综述。
Thyroid. 2010 Jul;20(7):795-801. doi: 10.1089/thy.2009.0216.
9
FOXE1 polymorphisms are associated with familial and sporadic nonmedullary thyroid cancer susceptibility.FOXE1 多态性与家族性和散发性非髓样甲状腺癌易感性相关。
Clin Endocrinol (Oxf). 2012 Dec;77(6):926-33. doi: 10.1111/j.1365-2265.2012.04505.x.
10
The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinoma.FOXE1 基因座是家族性非髓样甲状腺癌的一个主要遗传决定因素。
Int J Cancer. 2014 May 1;134(9):2098-107. doi: 10.1002/ijc.28543. Epub 2013 Oct 31.

引用本文的文献

1
Papillary Thyroid Carcinoma, Cushing Disease, and Adrenocortical Carcinoma in a Patient with Li-Fraumeni Syndrome.一名患有李-弗劳梅尼综合征患者的甲状腺乳头状癌、库欣病和肾上腺皮质癌
AACE Clin Case Rep. 2024 Mar 28;10(4):127-131. doi: 10.1016/j.aace.2024.03.007. eCollection 2024 Jul-Aug.
2
Identification of Novel Candidate Genes for Familial Thyroid Cancer by Whole Exome Sequencing.全外显子组测序鉴定家族性甲状腺癌的新候选基因。
Int J Mol Sci. 2023 Apr 25;24(9):7843. doi: 10.3390/ijms24097843.
3
Metformin Decreases Serum Thyroglobulin Concentration in Nonmedullary Thyroid Carcinoma.
二甲双胍可降低非髓样甲状腺癌患者的血清甲状腺球蛋白浓度。
J Endocr Soc. 2022 Sep 13;6(11):bvac140. doi: 10.1210/jendso/bvac140. eCollection 2022 Oct 11.
4
Identification of NID1 as a novel candidate susceptibility gene for familial non-medullary thyroid carcinoma using whole-exome sequencing.通过全外显子组测序鉴定NID1作为家族性非髓样甲状腺癌的新型候选易感基因。
Endocr Connect. 2022 Jan 31;11(1):e210406. doi: 10.1530/EC-21-0406.
5
Papillary Thyroid Cancer Affecting Multiple Family Members: A Case Report and Literature Review of Familial Nonmedullary Thyroid Cancer.影响多名家庭成员的乳头状甲状腺癌:一例家族性非髓样甲状腺癌病例报告及文献综述
Case Rep Endocrinol. 2021 Oct 15;2021:3472000. doi: 10.1155/2021/3472000. eCollection 2021.
6
Genetics of Familial Non-Medullary Thyroid Carcinoma (FNMTC).家族性非髓样甲状腺癌(FNMTC)的遗传学
Cancers (Basel). 2021 Apr 30;13(9):2178. doi: 10.3390/cancers13092178.
7
Familial non-medullary thyroid cancer: a critical review.家族性非髓样甲状腺癌:批判性综述。
J Endocrinol Invest. 2021 May;44(5):943-950. doi: 10.1007/s40618-020-01435-x. Epub 2020 Oct 6.
8
Clinicopathologic Results of the Surgical Management of Thyroid Gland Pathologies.甲状腺疾病外科治疗的临床病理结果
Turk Arch Otorhinolaryngol. 2020 Jun;58(2):93-98. doi: 10.5152/tao.2020.5276. Epub 2020 Jun 1.
9
The impact of family history on non-medullary thyroid cancer.家族史对非髓样甲状腺癌的影响。
Eur J Surg Oncol. 2016 Oct;42(10):1455-63. doi: 10.1016/j.ejso.2016.08.006. Epub 2016 Aug 11.
10
HABP2 germline variants are uncommon in familial nonmedullary thyroid cancer.HABP2种系变异在家族性非髓样甲状腺癌中并不常见。
BMC Med Genet. 2016 Aug 17;17(1):60. doi: 10.1186/s12881-016-0323-1.